ING4 and central nervous system cancer: It is believed, based on knockdown and overexpression experiments in gliomas, that ING4 interacts with the NF-κB complex by binding to RelA, leading to the downregulation of NF-κB target genes, which reinforces the idea that ING4 shows characteristics of a tumor suppressor [79].